Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.
作者信息
Shirazi Farshad M, Banerji Shireen, Nakhaee Samaneh, Mehrpour Omid
机构信息
Arizona Poison & Drug Information Center, University of Arizona, College of Pharmacy and University of Arizona College of Medicine, Tucson, AZ, USA.
Denver Health/Rocky Mountain Poison and Drug Safety, Denver, CO, USA.
出版信息
Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):2001-2002. doi: 10.1007/s10096-020-03932-6. Epub 2020 Jun 16.
Abstract
摘要
相似文献
1
Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.
Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):2001-2002. doi: 10.1007/s10096-020-03932-6. Epub 2020 Jun 16.
2
Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis.
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):335-337. doi: 10.1093/ehjcvp/pvaa074.
3
Covid-19: Time for a paradigm change.
Rev Med Virol. 2020 Sep;30(5):e2134. doi: 10.1002/rmv.2134. Epub 2020 Jul 3.
4
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
Biofactors. 2020 May;46(3):306-308. doi: 10.1002/biof.1633. Epub 2020 Apr 27.
5
Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
J Mol Cell Cardiol. 2020 Sep;146:41-42. doi: 10.1016/j.yjmcc.2020.07.005. Epub 2020 Jul 18.
6
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Int Arch Allergy Immunol. 2020;181(6):467-475. doi: 10.1159/000508247. Epub 2020 May 11.
7
COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.
Open Heart. 2020 Jun;7(1). doi: 10.1136/openhrt-2020-001302.
8
Pre- and post-treatment chest CT changes in a patient with COVID-19.
Med Clin (Barc). 2020 Jul 10;155(1):49. doi: 10.1016/j.medcli.2020.04.005. Epub 2020 Apr 23.
9
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
Int J Antimicrob Agents. 2020 Sep;56(3):106125. doi: 10.1016/j.ijantimicag.2020.106125. Epub 2020 Jul 30.
10
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
Trends Immunol. 2020 Oct;41(10):856-859. doi: 10.1016/j.it.2020.08.001. Epub 2020 Aug 10.
引用本文的文献
1
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy.
Front Immunol. 2023 Feb 17;14:1127358. doi: 10.3389/fimmu.2023.1127358. eCollection 2023.
2
A double-edged sword of using opioids and COVID-19: a toxicological view.
Subst Abuse Treat Prev Policy. 2020 Dec 3;15(1):91. doi: 10.1186/s13011-020-00333-y.
本文引用的文献
1
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease.
Molecules. 2020 Apr 29;25(9):2076. doi: 10.3390/molecules25092076.
2
COVID-19, ACE2, and the cardiovascular consequences.
Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1084-H1090. doi: 10.1152/ajpheart.00217.2020. Epub 2020 Mar 31.
3
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
4
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
Hypertension. 2020 Jun;75(6):1382-1385. doi: 10.1161/HYPERTENSIONAHA.120.15082. Epub 2020 Mar 25.
5
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
6
[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 16;43(0):E014. doi: 10.3760/cma.j.issn.1001-0939.2020.0014.
7
The COVID-19 epidemic.
Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.
8
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
9
Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H137-52. doi: 10.1152/ajpheart.00618.2015. Epub 2015 Oct 16.
10
Angiotensin II antagonists - an assessment of their acute toxicity.
Clin Toxicol (Phila). 2013 Jun;51(5):429-34. doi: 10.3109/15563650.2013.800875. Epub 2013 May 22.
Zotero 插件